Want to join the conversation?
$MYL 2Q15 Call: Our EpiPen continues to post strong results and maintains an 86% share in a multi-epinephrine market, and has delivered double-digit growth year-to-date. On the bottom line, our adjusted diluted earnings per share came in at $0.91 for the second quarter, up 32% compared to the same period last year, and exceeding our expectations.
When you fall hard, I think you stay there for a long time.. I am looking at you $FTNT! After it released the earnings, the share price slipped and is staying around $30 for a long time.
$FOXA just entered into a preliminary deal with Sky plc under which it will acquire all shares, or should I say remaining shares for a total value of $23 billion. The sleeping fox catches no poultry, but this fox just caught something that’s a lot bigger than poultry.
$BIG looks promising to me. Feels like it’s a good time to put some money on it.
$TWTR rolled out an iOS update Dec. 8 night that killed its famous "@" symbol. This lead to confusion among the iOS users when they tried it to reply to tweets.